This is a standard annual proxy filing. Traders should note the shareholder vote dates and proposals, but no immediate trading action is required based on this document. Monitor for any unexpected outcomes from the shareholder vote, though the board's unanimous recommendation suggests a low likelihood of surprises.
Price Chart
Executive Summary
Edwards Lifesciences Corp filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting of Stockholders, scheduled for May 7, 2026. The filing outlines four proposals for shareholder vote: election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program. The board recommends voting in favor of all proposals.
Key Facts
- Filing is a definitive proxy statement (DEFA14A) for the 2026 Annual Meeting of Stockholders.
- Meeting is scheduled for May 7, 2026, and will be held via webcast.
- Proposals include the election of nine directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of an amended long-term stock incentive program.
- The board of directors recommends a vote in favor of all proposals.
- The filing is routine, administrative, and contains no new financial data or material changes.
Financial Impact
No immediate financial impact. This is a routine governance filing.
Risk Factors
- Low risk of shareholder revolt on any proposal due to the board's strong recommendation.
- Potential for minor governance concerns if any director receives significant withhold votes, though this is not indicated in the filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFA14A Filing (Primary) | 0001099800-26-000016 |
| Document: 0001099800-26-000016-index-headers.html | 0001099800-26-000016 |
| Document: 0001099800-26-000016-index.html | 0001099800-26-000016 |
| Document: 0001099800-26-000016.txt | 0001099800-26-000016 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 31, 2026 4w ago | Insider Cluster | $90.74 $86.32 | ▼ −4.87% | ▼ −5.19% | $85.76 (−5.49%) |
Aug 28, 2026 5w ago | Insider Cluster | $90.21 $86.29 | ▼ −4.35% | ▼ −4.85% | $85.76 (−4.93%) |
Aug 26, 2026 5w ago | Insider Cluster | $89.95 $85.47 | ▼ −4.99% | ▼ −4.88% | $85.76 (−4.66%) |
Aug 10, 2026 7w ago | Court Ruling | $91.94 $86.72 | ▼ −5.67% | ▼ −4.76% | $85.76 (−6.72%) |
Jul 30, 2026 9w ago | Insider Cluster | $86.07 $90.21 | ▲ +4.81% | ▲ +1.82% | $85.76 (−0.36%) |
Jul 28, 2026 9w ago | Insider Cluster | $85.76 $90.78 | ▲ +5.85% | ▲ +0.83% | $85.76 (+0.00%) |
May 29, 2026 17w ago | Insider Cluster | $88.17 $91.18 | ▲ +3.42% | ▲ +5.73% | $85.76 (−2.73%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.76 (+4.45%) |
May 18, 2026 19w ago | Insider Cluster | $82.11 $88.58 | ▲ +7.88% | ▲ +5.62% | $85.76 (+4.45%) |
May 8, 2026 20w ago | 8-K | $77.08 $87.54 | ▲ +13.57% | ▲ +13.88% | $85.76 (+11.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access